Page last updated: 2024-10-16

adenine and Duncan Disease

adenine has been researched along with Duncan Disease in 15 studies

Research Excerpts

ExcerptRelevanceReference
" Limited data have been published about the infection risk associated with these new drugs, therefore this study analyzes the infectious complications in patients with lymphoproliferative diseases (LPD) treated with monoclonal antibodies (obinutuzumab, ofatumumab, brentuximab, nivolumab, or pembrolizumab), BTK inhibitors (ibrutinib and acalabrutinib), PI3K inhibitors (idelalisib) and BCL2 inhibitors (venetoclax)."4.02Severe infections in patients with lymphoproliferative diseases treated with new targeted drugs: A multicentric real-world study. ( Alonso, C; Ángel Hernández-Rivas, J; Bastidas, G; Bastos-Oreiro, M; Bocanegra, A; Carpio, C; Comai, A; Cordoba, R; De Nicolás, R; Del Campo, R; Fernández-Cruz, A; García-Suárez, J; Grande, C; Jiménez-Ubieto, A; López-Guillermo, A; López-Jiménez, J; Luis Plana, J; Marquet, J; Martín, X; Martínez-López, J; Mas-Ochoa, C; Morillo, D; Navarro-Matilla, B; Núñez, L; Prat, M; Romero, S; Ruiz-Camps, I; Seri, C; Serna, Á; Stefania Infante, M; Vásquez, L; Villafuerte, P, 2021)
"We describe the opportunistic infections occurring in 362 patients with lymphoproliferative disorders treated with ibrutinib and idelalisib in clinical practice."4.02Infections in patients with lymphoproliferative diseases treated with targeted agents: SEIFEM multicentric retrospective study. ( Busca, A; Candoni, A; Cattaneo, C; Dargenio, M; Facchinelli, D; Fanci, R; Farina, F; Laurenti, L; Lessi, F; Marchesi, F; Marchesini, G; Nadali, G; Pagano, L; Picardi, M; Prezioso, L; Spolzino, A; Tisi, MC; Trastulli, F; Verga, L; Visentin, A, 2021)
"She was diagnosed with cold agglutinin disease (CAD) and treated with corticosteroids."1.62[Small B-cell neoplasm responding to ibrutinib after 17 years of cold agglutinin disease symptom]. ( Haga, H; Hishizawa, M; Hori, T; Iga, Y; Kondo, T; Masuda, K; Morimoto, S; Morita, M; Shindo, T; Takaori-Kondo, A; Yamashita, K; Yurugi, K, 2021)
" However, BTKi have a range of drug-drug and drug-food interactions, which may alter drug efficacy and/or increase toxicity."1.56Drug interactions with Bruton's tyrosine kinase inhibitors: clinical implications and management. ( Fancher, KM; Pappacena, JJ, 2020)

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's8 (53.33)24.3611
2020's7 (46.67)2.80

Authors

AuthorsStudies
Stefania Infante, M1
Fernández-Cruz, A1
Núñez, L1
Carpio, C1
Jiménez-Ubieto, A1
López-Jiménez, J1
Vásquez, L1
Del Campo, R1
Romero, S1
Alonso, C1
Morillo, D1
Prat, M1
Luis Plana, J1
Villafuerte, P1
Bastidas, G1
Bocanegra, A1
Serna, Á1
De Nicolás, R1
Marquet, J1
Mas-Ochoa, C1
Cordoba, R1
García-Suárez, J1
Comai, A1
Martín, X1
Bastos-Oreiro, M1
Seri, C1
Navarro-Matilla, B1
López-Guillermo, A1
Martínez-López, J1
Ángel Hernández-Rivas, J1
Ruiz-Camps, I2
Grande, C1
Morimoto, S1
Shindo, T1
Iga, Y1
Morita, M1
Yurugi, K1
Masuda, K1
Hori, T1
Hishizawa, M1
Kondo, T1
Yamashita, K1
Haga, H1
Takaori-Kondo, A1
Los-Arcos, I1
Aguilar-Company, J1
Kallam, A1
Hansen, N1
Bierman, P1
Fancher, KM1
Pappacena, JJ1
Marchesini, G1
Nadali, G1
Facchinelli, D1
Candoni, A1
Cattaneo, C1
Laurenti, L1
Fanci, R1
Farina, F1
Lessi, F1
Visentin, A2
Marchesi, F1
Prezioso, L1
Spolzino, A1
Tisi, MC1
Trastulli, F1
Picardi, M1
Verga, L1
Dargenio, M1
Busca, A1
Pagano, L1
Law, SC1
Hoang, T1
O'Rourke, K1
Tobin, JWD1
Gunawardana, J1
Loo-Oey, D1
Bednarska, K1
Merida de Long, L1
Sabdia, MB1
Hapgood, G1
Blyth, E1
Clancy, L1
Hennig, S1
Keane, C1
Gandhi, MK1
Regan, JA1
Cao, Y1
Dispenza, MC1
Ma, S1
Gordon, LI1
Petrich, AM1
Bochner, BS1
Xu, RA1
Wen, J1
Tang, P1
Wang, C1
Xie, S1
Zhang, BW1
Zhou, Q1
Cai, JP1
Hu, GX1
Cheng, C1
Woronow, D1
Nayernama, A1
Wroblewski, T1
Jones, SC1
Campello, E1
Scomazzon, E1
Spiezia, L1
Imbergamo, S1
Pravato, S1
Piazza, F1
Semenzato, G1
Simioni, P1
Trentin, L1
Schwarzbich, MA1
Witzens-Harig, M1
Viganò, M1
Mangia, G1
Lampertico, P1
Berglöf, A1
Hamasy, A1
Meinke, S1
Palma, M1
Krstic, A1
Månsson, R1
Kimby, E1
Österborg, A1
Smith, CI1
Cabras, MG1
Angelucci, E1

Reviews

4 reviews available for adenine and Duncan Disease

ArticleYear
Risk of infection associated with new therapies for lymphoproliferative syndromes.
    Medicina clinica, 2020, 02-14, Volume: 154, Issue:3

    Topics: Adenine; Alemtuzumab; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Agent

2020
Ibrutinib.
    Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 2014, Volume: 201

    Topics: Adenine; Animals; Antineoplastic Agents; B-Lymphocytes; Humans; Lymphoproliferative Disorders; Piper

2014
Management of patients with overt or resolved hepatitis B virus infection undergoing rituximab therapy.
    Expert opinion on biological therapy, 2014, Volume: 14, Issue:7

    Topics: Adenine; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Monoclonal, Murine-

2014
Targets for Ibrutinib Beyond B Cell Malignancies.
    Scandinavian journal of immunology, 2015, Volume: 82, Issue:3

    Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; Animals; Atrial Fibrillation; Humans; Leukemia, Lympho

2015

Other Studies

11 other studies available for adenine and Duncan Disease

ArticleYear
Severe infections in patients with lymphoproliferative diseases treated with new targeted drugs: A multicentric real-world study.
    Cancer medicine, 2021, Volume: 10, Issue:21

    Topics: Adenine; Adolescent; Adult; Agammaglobulinaemia Tyrosine Kinase; Aged; Aged, 80 and over; Antibodies

2021
[Small B-cell neoplasm responding to ibrutinib after 17 years of cold agglutinin disease symptom].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2021, Volume: 62, Issue:12

    Topics: Adenine; Aged; Anemia, Hemolytic, Autoimmune; Female; Humans; Lymphoproliferative Disorders; Neoplas

2021
Central Nervous System Post-transplant Lymphoproliferative Disorder: Response to Ibrutinib.
    Clinical lymphoma, myeloma & leukemia, 2020, Volume: 20, Issue:11

    Topics: Adenine; Central Nervous System; Female; Humans; Lymphoproliferative Disorders; Male; Middle Aged; P

2020
Drug interactions with Bruton's tyrosine kinase inhibitors: clinical implications and management.
    Cancer chemotherapy and pharmacology, 2020, Volume: 86, Issue:4

    Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; Benzamides; Citrus paradisi; Citrus sinensis; Comorbid

2020
Infections in patients with lymphoproliferative diseases treated with targeted agents: SEIFEM multicentric retrospective study.
    British journal of haematology, 2021, Volume: 193, Issue:2

    Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; Aged; Aged, 80 and over; Bacterial Infections; Case-Co

2021
Successful treatment of Epstein-Barr virus-associated primary central nervous system lymphoma due to post-transplantation lymphoproliferative disorder, with ibrutinib and third-party Epstein-Barr virus-specific T cells.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2021, Volume: 21, Issue:10

    Topics: Adenine; Central Nervous System; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Lympho

2021
Ibrutinib, a Bruton's tyrosine kinase inhibitor used for treatment of lymphoproliferative disorders, eliminates both aeroallergen skin test and basophil activation test reactivity.
    The Journal of allergy and clinical immunology, 2017, Volume: 140, Issue:3

    Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; Aged; Allergens; Anti-Allergic Agents; Basophils; Huma

2017
Functional Characterization of 22 CYP3A4 Protein Variants to Metabolize Ibrutinib In Vitro.
    Basic & clinical pharmacology & toxicology, 2018, Volume: 122, Issue:4

    Topics: Adenine; Antineoplastic Agents; Cytochrome P-450 CYP3A; Enzyme Assays; Humans; Lymphoproliferative D

2018
Ibrutinib-associated ventricular arrhythmia in the FDA Adverse Event Reporting System.
    Leukemia & lymphoma, 2018, Volume: 59, Issue:12

    Topics: Adenine; Adverse Drug Reaction Reporting Systems; Aged; Arrhythmias, Cardiac; Drug Monitoring; Femal

2018
Dabigatran in ibrutinib-treated patients with atrial fibrillation and lymphoproliferative diseases: Experience of 4 cases.
    Hematological oncology, 2018, Volume: 36, Issue:5

    Topics: Adenine; Aged; Aged, 80 and over; Atrial Fibrillation; Dabigatran; Female; Humans; Lymphoproliferati

2018
Ibrutinib: another weapon in our arsenal against lympho-proliferative disorders.
    Expert opinion on pharmacotherapy, 2015, Volume: 16, Issue:18

    Topics: Adenine; Antineoplastic Agents; Humans; Lymphoproliferative Disorders; Piperidines; Pyrazoles; Pyrim

2015